A look at the impact of prehypertension on the risk of stillbirth. And, the CDC issues guidance on alcohol consumption in women of childbearing years. Plus: Does the type of hysterectomy alter endometrial cancer survival?
It may difficult to arrive at a diagnosis in cases of acute pain.
Women with BRCA gene mutations face tough decisions but they have options.
A self-sampling device being used in Canada is receiving high marks from patients.
Geographic factors predict likelihood of HPV vaccine initiation rates, a study finds.
If proven effective, the vaccine, called VGX-3100, would be the first non-ablative therapy for cervical precancer.
The study was designed for tight control of the usual variables.
A January 4th action by the US Food and Drug Administration (FDA) reclassified transvaginal mesh implants for pelvic organ prolapse (POP) as class III (or high-risk) medical devices requiring premarket approval application (PMA).
Did it occur during surgery, or did a later injury lead to it?
Surgical mesh for pelvic organ prolapse (POP) is a class III or high-risk medical device requiring premarket approval application (PMA) following new action by the Food and Drug Administration (FDA).